Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms Rowe BP; Glazer PMBreast Cancer Res 2010[]; 12 (2): 203Accumulating evidence suggests that many cancers, including BRCA1- and BRCA2-associated breast cancers, are deficient in DNA repair processes. Both hereditary and sporadic breast cancers have been found to have significant downregulation of repair factors. This has provided opportunities to exploit DNA repair deficiencies, whether acquired or inherited. Here, we review efforts to exploit DNA repair deficiencies in tumors, with a focus on breast cancer. A variety of agents, including PARP (poly [ADP-ribose] polymerase) inhibitors, are currently under investigation in clinical trials and available results will be reviewed.|*Poly(ADP-ribose) Polymerase Inhibitors[MESH]|Antineoplastic Agents/*therapeutic use[MESH]|Benzimidazoles/therapeutic use[MESH]|Breast Neoplasms/*drug therapy/genetics[MESH]|Clinical Trials as Topic[MESH]|DNA Damage[MESH]|DNA Repair/*drug effects[MESH]|Female[MESH]|Humans[MESH]|Indoles/therapeutic use[MESH]|Poly(ADP-ribose) Polymerases/metabolism[MESH] |